Table 1.
Baseline characteristics of patients with acute HF and control group.
| Characteristics | Acute Heart Failure (No = 120) |
Control Group (No = 53) |
p-Value | |
|---|---|---|---|---|
| Mean ± STD | Mean ± STD | |||
| Age (years) | 66.4 ± 15.3 | 64 ± 11.9 | 0.526 | |
| In-hospital mortality rate: No, (%) | 21 (12.1%) | 0 (0%) | <0.001 | |
| Gender | Men | 71 (59.20%) |
33 (62.30%) |
0.438 |
| Women | 49 (40.80%) |
20 (37.70%) |
||
| Smoking: No, (%) |
48 (40%) |
19 (35.8%) |
0.605 | |
| Alcohol abuse: No, (%) |
75 (62.5%) | 22 (41.5%) | 0.012 | |
| Arterial hypertension: No, (%) |
60 (50%) |
34 (64.2%) |
0.085 | |
| Ischemic heart disease: No, (%) | 59 (49.2%) | 17 (32%) |
0.037 | |
| Diabetes mellitus No, (%) |
22 (18.3%) | 7 (13.2%) | 0.406 | |
| BMI > 30 kg/m2 N, (%) |
42 (35%) | 7 (13.2%) | 0.003 | |
| LVEF | 33.8 ± 13.9% | 52.2 ± 15.7 | 0.017 | |
| Anemia: No, (%) | 35 (29.2%) | 12(22.7%) | 0.377 | |
| Loop diuretics | 102 (85%) | 17 (32.1%) | <0.001 | |
| MRA | 83 (69.2%) | 9 (17%) | <0.001 | |
| Beta-blockers | 99 (82.5%) | 49 (92.5%) | 0.087 | |
| RAS inhibitor | 77 (64.2%) | 44 (83.1%) | 0.012 | |
BMI—body mass index; LVEF—left ventricle ejection fraction; MRA—mineralocorticoid receptor antagonist; RAS—renin-angiotensin-system.